Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
The fat is in the lysosome: how Mycobacterium tuberculosis tricks macrophages into storing lipids
Yoann Rombouts, Olivier Neyrolles
Yoann Rombouts, Olivier Neyrolles
Published March 15, 2023
Citation Information: J Clin Invest. 2023;133(6):e168366. https://doi.org/10.1172/JCI168366.
View: Text | PDF
Commentary

The fat is in the lysosome: how Mycobacterium tuberculosis tricks macrophages into storing lipids

  • Text
  • PDF
Abstract

Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), infects primarily macrophages, causing them to differentiate into lipid-laden foamy macrophages that are a primary source of tissue destruction in patients with TB. In this issue of the JCI, Bedard et al. demonstrate that 1-tuberculosinyladenosine, a virulence factor produced by M. tuberculosis, caused lysosomal dysfunction associated with lipid storage in the phagolysosome of macrophages in a manner that mimicked lysosomal storage diseases. This work sheds light on how M. tuberculosis manipulates host lipid metabolism for its survival and opens avenues toward host-directed therapy against TB.

Authors

Yoann Rombouts, Olivier Neyrolles

×

Figure 1

1-TbAd produced by M. tuberculosis induces lysosomal lipid storage.

Options: View larger image (or click on image) Download as PowerPoint
1-TbAd produced by M. tuberculosis induces lysosomal lipid storage.
(i) ...
(i) M. tuberculosis (Mtb) produces 1-TbAd, which raises the vacuolar pH and inhibits acidic hydrolases, including lipases, inside the phagolysosome. (ii) Consequently, lipids, including cholesteryl esters and triglycerides, accumulate in the vacuole, mimicking lysosomal storage diseases. (iii) Under conditions of restricted lipid access, M. tuberculosis can use these lipids as a carbon source to promote its intracellular growth.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts